HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of the experimental antitumor activities of three nitrosourea derivatives chlorozotocin, RFCNU and CNCC encapsulated in liposomes with those in the free state.

Abstract
L1210 leukemia was used to compare the antitumor activities of three nitrosoureas (chlorozotocin, RFCNU and CNCC) encapsulated in liposomes with those in the free state. The results obtained varied according to the chemical structure of the compound, its solubility in oil or water, the route of administration into the body, and the treatment dose. The application of liposomes in the chemotherapy of malignant disease deserves further investigations.
AuthorsR Maral, C Bourut, E Chenu, G Mathe, R Bernon, C Lussan, J L Imbach, P Schein, P Bothorel
JournalOncology (Oncology) Vol. 42 Issue 2 Pg. 122-8 ( 1985) ISSN: 0030-2414 [Print] Switzerland
PMID3157909 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Liposomes
  • Nitrosourea Compounds
  • chlorozotocin
  • RFCNU
  • Streptozocin
  • N,N'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine
Topics
  • Animals
  • Antineoplastic Agents (therapeutic use)
  • Half-Life
  • Leukemia L1210 (drug therapy)
  • Liposomes (administration & dosage)
  • Male
  • Mice
  • Neoplasm Transplantation
  • Nitrosourea Compounds (therapeutic use)
  • Streptozocin (analogs & derivatives, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: